» Articles » PMID: 12423250

Brief, Repeated Exposure to Substrates Down-regulates Dopamine Transporter Function in Xenopus Oocytes in Vitro and Rat Dorsal Striatum in Vivo

Overview
Journal J Neurochem
Specialties Chemistry
Neurology
Date 2002 Nov 9
PMID 12423250
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

In heterologous expression systems, dopamine transporter (DAT) cell-surface localization is reduced after relatively prolonged exposure to d-amphetamine (AMPH) or dopamine (DA), suggesting a role for substrate-mediated regulation of transporter function. Here, we investigated whether brief, repeated periods of substrate exposure modulated transporter function, first, in an in vitro model system and, second, in intact rat brain. In human DAT-expressing Xenopus laevis oocytes, repeated exposure to low micromolar concentrations of DA, AMPH or tyramine markedly reduced transport-mediated currents. This functional down-regulation was attenuated by inclusion of a protein kinase C (PKC) inhibitor and probably reflects DAT redistribution, as cell-surface [3H]WIN 35 428 binding was significantly lower following DA exposure. High-speed chronoamperometry was used to measure clearance of exogenously applied DA in dorsal striatum (STR) and nucleus accumbens (NAc) of anesthetized rats. In STR, frequent (every 2 min) applications of DA altered DA clearance parameters in a manner consistent with profound down-regulation of DAT function. Similar changes were not observed in NAc or after repeated vehicle (ascorbic acid) application. Together, our results suggest that brief, repeated periods of substrate exposure lead to rapid down-regulation of DAT activity and that this type of regulation can occur in vivo in STR, but not NAc.

Citing Articles

Methamphetamine Dysregulation of the Central Nervous System and Peripheral Immunity.

Miller D, Bu M, Gopinath A, Martinez L, Khoshbouei H J Pharmacol Exp Ther. 2021; 379(3):372-385.

PMID: 34535563 PMC: 9351721. DOI: 10.1124/jpet.121.000767.


Regulation of Glutamate, GABA and Dopamine Transporter Uptake, Surface Mobility and Expression.

Ryan R, Ingram S, Scimemi A Front Cell Neurosci. 2021; 15:670346.

PMID: 33927596 PMC: 8076567. DOI: 10.3389/fncel.2021.670346.


Dopamine transporter function fluctuates across sleep/wake state: potential impact for addiction.

Alonso I, Pino J, Kortagere S, Torres G, Espana R Neuropsychopharmacology. 2020; 46(4):699-708.

PMID: 33032296 PMC: 8026992. DOI: 10.1038/s41386-020-00879-2.


In Situ Regulated Dopamine Transporter Trafficking: There's No Place Like Home.

Fagan R, Kearney P, Melikian H Neurochem Res. 2020; 45(6):1335-1343.

PMID: 32146647 PMC: 7261626. DOI: 10.1007/s11064-020-03001-6.


Prolonged Amphetamine Treatments Cause Long-Term Decrease of Dopamine Uptake in Cultured Cells.

Ferdous N, Kudumala S, Sossi S, Carvelli L Neurochem Res. 2019; 45(6):1399-1409.

PMID: 31883055 PMC: 7260268. DOI: 10.1007/s11064-019-02938-7.